RN7SL864P

Across TCGA pan-cancer cohorts, RN7SL864P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RN7SL864P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL864P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL864P expression acts as an unfavorable survival marker, although some lineages such as HNSC and BRCA show a favorable association.

HNSC, KIRC, and MESO are the cancer types where RN7SL864P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	III,IV	0.825	0.305	.006	78	view →
KIRC	DFS	Tertile	IV	0.433	0.676	.006	39	view →
MESO	DFS	Tertile	III,IV	0.088	0.421	<.001	36	view →
LUSC	OS	Tertile	III,IV	0.275	0.591	.008	36	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
BRCA	OS	Tertile	All	0.988	0.957	.017	33	view →
OV	OS	Tertile	All	0.793	0.854	.008	30	view →
THCA	OS	Tertile	II,III,IV	0.490	0.928	<.001	30	view →
SKCM	DFS	Tertile	IV	0.502	0.203	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RN7SL864P–HNSC (DFS)

Open the HNSC breakdown →